12:00pm Overcoming Tumor Resistance With Amanitin-Based ADCs – Insights From the Clinic
Time: 12:00 pm
day: Day One Preclinical & Clinical Development Track
Details:
- Discussing the trends and advantages of dual-payload ADCs to combat resistance
- Overviewing dual-payload ADCs generated from the co-Nectar platform
- Sharing HoneyBear Biosciences portfolio of dual-payload ADCs, and future plans
